LMAN2
Basic information
Region (hg38): 5:177315805-177351840
Previous symbols: [ "C5orf8" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMAN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 1 | 2 |
Variants in LMAN2
This is a list of pathogenic ClinVar variants found in the LMAN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-177332142-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
5-177332169-C-T | Benign (Sep 29, 2018) | |||
5-177332201-G-A | not specified | Uncertain significance (Feb 17, 2022) | ||
5-177334289-G-C | not specified | Uncertain significance (Dec 19, 2023) | ||
5-177334361-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
5-177334381-C-A | not specified | Uncertain significance (Aug 30, 2022) | ||
5-177337174-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
5-177337373-C-T | not specified | Uncertain significance (May 24, 2024) | ||
5-177337386-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
5-177337395-G-C | not specified | Uncertain significance (Mar 01, 2024) | ||
5-177337413-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
5-177337418-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
5-177337523-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
5-177337737-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
5-177337783-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
5-177338521-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
5-177338557-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
5-177351255-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
5-177351261-T-G | not specified | Uncertain significance (Nov 10, 2022) | ||
5-177351532-A-G | Benign (Sep 19, 2018) | |||
5-177351551-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
5-177351581-G-C | not specified | Uncertain significance (Oct 16, 2023) | ||
5-177351612-C-G | not specified | Uncertain significance (Jan 06, 2023) | ||
5-177351614-A-T | not specified | Uncertain significance (Aug 22, 2023) | ||
5-177351622-C-A | not specified | Likely benign (Nov 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LMAN2 | protein_coding | protein_coding | ENST00000303127 | 8 | 20291 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000107 | 0.952 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.382 | 234 | 251 | 0.932 | 0.0000170 | 2336 |
Missense in Polyphen | 95 | 124.39 | 0.76373 | 1126 | ||
Synonymous | -1.09 | 125 | 110 | 1.13 | 0.00000834 | 706 |
Loss of Function | 1.79 | 9 | 16.9 | 0.532 | 7.26e-7 | 180 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000867 | 0.0000867 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000806 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role as an intracellular lectin in the early secretory pathway. Interacts with N-acetyl-D-galactosamine and high-mannose type glycans and may also bind to O-linked glycans. Involved in the transport and sorting of glycoproteins carrying high mannose-type glycans (By similarity). {ECO:0000250}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Cargo concentration in the ER;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.506
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.58
Haploinsufficiency Scores
- pHI
- 0.129
- hipred
- N
- hipred_score
- 0.329
- ghis
- 0.565
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.798
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lman2
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;endoplasmic reticulum organization;Golgi organization;protein transport;positive regulation of phagocytosis
- Cellular component
- Golgi membrane;extracellular space;endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment;Golgi apparatus;integral component of plasma membrane;cell surface;COPII-coated ER to Golgi transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;extracellular exosome
- Molecular function
- protein binding;mannose binding;carbohydrate binding;heat shock protein binding;metal ion binding